table of content
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Novel Coronavirus (COVID-19) Vaccine
1.2 Key Market Segments
1.2.1 Novel Coronavirus (COVID-19) Vaccine Segment by Type
1.2.2 Novel Coronavirus (COVID-19) Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Novel Coronavirus (COVID-19) Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Novel Coronavirus (COVID-19) Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Novel Coronavirus (COVID-19) Vaccine Market Competitive Landscape
3.1 Global Novel Coronavirus (COVID-19) Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Novel Coronavirus (COVID-19) Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Novel Coronavirus (COVID-19) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Novel Coronavirus (COVID-19) Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Novel Coronavirus (COVID-19) Vaccine Sales Sites, Area Served, Product Type
3.6 Novel Coronavirus (COVID-19) Vaccine Market Competitive Situation and Trends
3.6.1 Novel Coronavirus (COVID-19) Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Novel Coronavirus (COVID-19) Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Novel Coronavirus (COVID-19) Vaccine Industry Chain Analysis
4.1 Novel Coronavirus (COVID-19) Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Novel Coronavirus (COVID-19) Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Novel Coronavirus (COVID-19) Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Novel Coronavirus (COVID-19) Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Novel Coronavirus (COVID-19) Vaccine Price by Type (2019-2024)
7 Novel Coronavirus (COVID-19) Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Novel Coronavirus (COVID-19) Vaccine Market Sales by Application (2019-2024)
7.3 Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Novel Coronavirus (COVID-19) Vaccine Sales Growth Rate by Application (2019-2024)
8 Novel Coronavirus (COVID-19) Vaccine Market Segmentation by Region
8.1 Global Novel Coronavirus (COVID-19) Vaccine Sales by Region
8.1.1 Global Novel Coronavirus (COVID-19) Vaccine Sales by Region
8.1.2 Global Novel Coronavirus (COVID-19) Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Novel Coronavirus (COVID-19) Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Novel Coronavirus (COVID-19) Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Novel Coronavirus (COVID-19) Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Novel Coronavirus (COVID-19) Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Novel Coronavirus (COVID-19) Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Inovio Pharmaceuticals
9.1.1 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Basic Information
9.1.2 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Overview
9.1.3 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.1.4 Inovio Pharmaceuticals Business Overview
9.1.5 Inovio Pharmaceuticals Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
9.1.6 Inovio Pharmaceuticals Recent Developments
9.2 Takis Biotech (Evvivax)
9.2.1 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Basic Information
9.2.2 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Overview
9.2.3 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.2.4 Takis Biotech (Evvivax) Business Overview
9.2.5 Takis Biotech (Evvivax) Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
9.2.6 Takis Biotech (Evvivax) Recent Developments
9.3 Zydus Cadila
9.3.1 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Basic Information
9.3.2 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Overview
9.3.3 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.3.4 Zydus Cadila Novel Coronavirus (COVID-19) Vaccine SWOT Analysis
9.3.5 Zydus Cadila Business Overview
9.3.6 Zydus Cadila Recent Developments
9.4 Codagenix, Inc.
9.4.1 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.4.2 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.4.3 Codagenix, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.4.4 Codagenix, Inc. Business Overview
9.4.5 Codagenix, Inc. Recent Developments
9.5 GeoVax, Inc.
9.5.1 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.5.2 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.5.3 GeoVax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.5.4 GeoVax, Inc. Business Overview
9.5.5 GeoVax, Inc. Recent Developments
9.6 Bravovax
9.6.1 Bravovax Novel Coronavirus (COVID-19) Vaccine Basic Information
9.6.2 Bravovax Novel Coronavirus (COVID-19) Vaccine Product Overview
9.6.3 Bravovax Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.6.4 Bravovax Business Overview
9.6.5 Bravovax Recent Developments
9.7 Janssen Pharmaceutical Companies
9.7.1 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Basic Information
9.7.2 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Overview
9.7.3 Janssen Pharmaceutical Companies Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.7.4 Janssen Pharmaceutical Companies Business Overview
9.7.5 Janssen Pharmaceutical Companies Recent Developments
9.8 Altimmune
9.8.1 Altimmune Novel Coronavirus (COVID-19) Vaccine Basic Information
9.8.2 Altimmune Novel Coronavirus (COVID-19) Vaccine Product Overview
9.8.3 Altimmune Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.8.4 Altimmune Business Overview
9.8.5 Altimmune Recent Developments
9.9 Vaxart
9.9.1 Vaxart Novel Coronavirus (COVID-19) Vaccine Basic Information
9.9.2 Vaxart Novel Coronavirus (COVID-19) Vaccine Product Overview
9.9.3 Vaxart Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.9.4 Vaxart Business Overview
9.9.5 Vaxart Recent Developments
9.10 CanSino Biologics
9.10.1 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Basic Information
9.10.2 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Overview
9.10.3 CanSino Biologics Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.10.4 CanSino Biologics Business Overview
9.10.5 CanSino Biologics Recent Developments
9.11 ExpreS2ion Biotechnologies ApS
9.11.1 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Basic Information
9.11.2 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product Overview
9.11.3 ExpreS2ion Biotechnologies ApS Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.11.4 ExpreS2ion Biotechnologies ApS Business Overview
9.11.5 ExpreS2ion Biotechnologies ApS Recent Developments
9.12 Clover Biopharmaceuticals
9.12.1 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Basic Information
9.12.2 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Overview
9.12.3 Clover Biopharmaceuticals Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.12.4 Clover Biopharmaceuticals Business Overview
9.12.5 Clover Biopharmaceuticals Recent Developments
9.13 GSK
9.13.1 GSK Novel Coronavirus (COVID-19) Vaccine Basic Information
9.13.2 GSK Novel Coronavirus (COVID-19) Vaccine Product Overview
9.13.3 GSK Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.13.4 GSK Business Overview
9.13.5 GSK Recent Developments
9.14 Vaxil Bio Ltd.
9.14.1 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.14.2 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.14.3 Vaxil Bio Ltd. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.14.4 Vaxil Bio Ltd. Business Overview
9.14.5 Vaxil Bio Ltd. Recent Developments
9.15 Generex
9.15.1 Generex Novel Coronavirus (COVID-19) Vaccine Basic Information
9.15.2 Generex Novel Coronavirus (COVID-19) Vaccine Product Overview
9.15.3 Generex Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.15.4 Generex Business Overview
9.15.5 Generex Recent Developments
9.16 Novavax, Inc.
9.16.1 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.16.2 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.16.3 Novavax, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.16.4 Novavax, Inc. Business Overview
9.16.5 Novavax, Inc. Recent Developments
9.17 Sanofi Pasteur
9.17.1 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Basic Information
9.17.2 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product Overview
9.17.3 Sanofi Pasteur Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.17.4 Sanofi Pasteur Business Overview
9.17.5 Sanofi Pasteur Recent Developments
9.18 Baylor
9.18.1 Baylor Novel Coronavirus (COVID-19) Vaccine Basic Information
9.18.2 Baylor Novel Coronavirus (COVID-19) Vaccine Product Overview
9.18.3 Baylor Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.18.4 Baylor Business Overview
9.18.5 Baylor Recent Developments
9.19 iBio, Inc.
9.19.1 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.19.2 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.19.3 iBio, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.19.4 iBio, Inc. Business Overview
9.19.5 iBio, Inc. Recent Developments
9.20 Moderna, Inc.
9.20.1 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Basic Information
9.20.2 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product Overview
9.20.3 Moderna, Inc. Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.20.4 Moderna, Inc. Business Overview
9.20.5 Moderna, Inc. Recent Developments
9.21 Curevac
9.21.1 Curevac Novel Coronavirus (COVID-19) Vaccine Basic Information
9.21.2 Curevac Novel Coronavirus (COVID-19) Vaccine Product Overview
9.21.3 Curevac Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.21.4 Curevac Business Overview
9.21.5 Curevac Recent Developments
9.22 ImmunoPrecise
9.22.1 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Basic Information
9.22.2 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product Overview
9.22.3 ImmunoPrecise Novel Coronavirus (COVID-19) Vaccine Product Market Performance
9.22.4 ImmunoPrecise Business Overview
9.22.5 ImmunoPrecise Recent Developments
10 Novel Coronavirus (COVID-19) Vaccine Market Forecast by Region
10.1 Global Novel Coronavirus (COVID-19) Vaccine Market Size Forecast
10.2 Global Novel Coronavirus (COVID-19) Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Region
10.2.4 South America Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Novel Coronavirus (COVID-19) Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Novel Coronavirus (COVID-19) Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Novel Coronavirus (COVID-19) Vaccine by Type (2025-2030)
11.1.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Novel Coronavirus (COVID-19) Vaccine by Type (2025-2030)
11.2 Global Novel Coronavirus (COVID-19) Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Novel Coronavirus (COVID-19) Vaccine Sales (K Units) Forecast by Application
11.2.2 Global Novel Coronavirus (COVID-19) Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
